A preliminary genome-wide screening of candidate genes altered in GBM revealed that the gene encoding the histone methyltransferase KMT5B (alias SUV420H1) is frequently hypermethylated and hypo-hydroxymethylated in this tumor type. This evidence concerns the gene PRDM9 and neoplasm.